Statement of Ownership (sc 13g)
June 11 2020 - 12:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
|
Q BioMed Inc.
|
|
(Name of Issuer)
|
|
|
|
Common Stock, par value $0.001 per share
|
|
(Title of Class of Securities)
|
|
|
|
74736N105
|
|
(CUSIP Number)
|
|
|
|
February 10, 2020
|
|
(Date of Event which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
|
|
¨ Rule 13d-1(b)
|
|
|
|
|
|
x Rule 13d-1(c)
|
|
|
|
|
|
¨ Rule 13d-1(d)
|
* The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
SCHEDULE 13G
|
1
|
Names of Reporting Persons
|
|
Ari Jatwes
|
|
2
|
Check the appropriate box if a member of a Group (see instructions)
|
(a) ¨
(b) x
|
|
3
|
Sec Use Only
|
|
|
|
4
|
Citizenship or Place of Organization
|
|
United States
|
|
Number of
Shares
Beneficially
Owned by Each
Reporting Person
With:
|
5
|
Sole Voting Power
|
|
1,375,000*
|
|
6
|
Shared Voting Power
|
|
0
|
|
7
|
Sole Dispositive Power
|
|
1,375,000*
|
|
8
|
Shared Dispositive Power
|
|
0
|
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
1,375,000*
|
|
10
|
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
|
|
¨
|
|
11
|
Percent of class represented by amount in row (9)
|
|
5.89%*
|
|
12
|
Type of Reporting Person (See Instructions)
|
|
IN
|
* Calculations are based on the deemed beneficial ownership
of 1,375,000 shares of Common Stock, which includes 665,000 shares of Common Stock held by the reporting person on the date of
this filing and the 710,000 shares of Common Stock that the reporting person has the right to acquire within 60 days, such that
the reporting person is deemed to be the beneficial owner of 5.89% of the Company’s outstanding Common Stock of 23,360,685
shares (which number is based on the Company’s outstanding shares of 22,650,685 as of May 20, 2020, plus the 710,000 shares
of Common Stock that the reporting person has the right to acquire within 60 days).
Page 2 of 6
|
(a)
|
Name of Issuer: Q BioMed Inc.
|
|
(b)
|
Address of Issuer’s Principal
Executive Offices:
c/o Ortoli Rosenstadt LLP
366
Madison Avenue, 3nd Floor
New
York, NY
|
|
(a)
|
Name of Person Filing: Ari Jatwes
|
|
(b)
|
Address of Principal Business Office
or, if None, Residence:
c/o Ortoli Rosenstadt LLP
366
Madison Avenue, 3nd Floor
New
York, NY
|
|
(c)
|
Citizenship: United States
|
|
(d)
|
Title and Class of Securities: Common Stock, par value $0.001 per share
|
|
Item 3.
|
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
|
(a)
|
¨
|
Broker or dealer registered under Section 15 of the Act;
|
|
|
|
|
|
|
|
(b)
|
¨
|
Bank as defined in Section 3(a)(6) of the Act;
|
|
|
|
|
|
|
|
(c)
|
¨
|
Insurance company as defined in Section 3(a)(19) of the Act;
|
|
|
|
|
|
|
|
(d)
|
¨
|
Investment company registered under Section 8 of the Investment Company Act of 1940;
|
|
|
|
|
|
|
|
(e)
|
¨
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
|
|
(f)
|
¨
|
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
|
|
(g)
|
¨
|
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
|
|
(h)
|
¨
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
|
|
(i)
|
¨
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
|
|
|
|
|
|
|
|
(j)
|
¨
|
A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
|
|
|
|
|
|
|
|
(k)
|
¨
|
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________
|
Page 3 of 6
Provide the following information regarding
the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
|
|
(a)
|
Amount beneficially owned: 1,375,000
|
|
|
(b)
|
Percentage of Class: 5.89%*
|
|
|
(c)
|
Number of shares as to which the person has:
|
|
|
i.
|
Sole Power to vote or to direct the vote: 1,375,000*
|
|
|
ii.
|
Shared power to vote or to direct the vote: 0
|
|
|
iii.
|
Sole power to dispose or to direct the disposition: 1,375,000*
|
|
|
iv.
|
Shared power to dispose or to direct the disposition: 0
|
* Calculations are based on the deemed beneficial
ownership of 1,375,000 shares of Common Stock, which includes 665,000 shares of Common Stock held by the reporting person on the
date of this filing and the 710,000 shares of Common Stock that the reporting person has the right to acquire within 60 days, such
that the reporting person is deemed to be the beneficial owner of 5.89% of the Company’s outstanding Common Stock of 23,360,685
shares (which number is based on the Company’s outstanding shares of 22,650,685 as of May 20, 2020, plus the 710,000 shares
of Common Stock that the reporting person has the right to acquire within 60 days).
Page 4 of 6
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
Not
Applicable.
|
Item 6.
|
Ownership of more than Five Percent on Behalf of Another Person.
|
Not
Applicable.
|
Item 7.
|
Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.
|
Not
Applicable.
|
Item 8.
|
Identification and classification of members of the group.
|
Not
Applicable.
|
Item 9.
|
Notice of Dissolution of Group.
|
Not
Applicable.
By
signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as participant in any transaction having that purpose or effect.
Page 5 of 6
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: June 11, 2020
|
ARI JATWES
/s/ Ari Jatwes
|
|
|
Ari Jatwes
|
|
Page 6 of 6
Q BioMed (CE) (USOTC:QBIO)
Historical Stock Chart
From Oct 2024 to Nov 2024
Q BioMed (CE) (USOTC:QBIO)
Historical Stock Chart
From Nov 2023 to Nov 2024
